Rituximab (Anti-CD20) Therapy of B-Cell Lymphomas: Direct Complement Killing is Superior to Cellular Effector Mechanisms.
HARJUNPAA, A.; JUNNIKKALA, S.; MERI, S.
[Miscellaneous Article] Scandinavian Journal of Immunology. 51(6):634-641, June 2000.

(Format: HTML)